CrushSCI.com
提供学术论文选刊润色服务
EXPERT OPINION ON BIOLOGICAL THERAPY 期刊封面 医学
返回期刊列表

Review Cycle Records

EXPERT OPINION ON BIOLOGICAL THERAPY

Taylor & Francis SCIE 非OA
2026新锐 3区2025中科院 3区2025 JCR Q2
77.6平均天数
69中位天数
39最短天数
145最长天数
1152025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

55 天

Efficacy and safety of golimumab biosimilar BAT2506 in patients with active psoriatic arthritis after switching from reference golimumab: 52-week results of a phase 3, double-blind, randomized study

作者Honghu Tang; Eva Dokoupilova; Bogdan Batko; Marek Zawadzki; Anastas Batalov; Yi Liu; Xiaolei Yang; Yinbo Zhou; Qingfeng Dong; Yi Liu

作者单位1. West China Hospital of Sichuan University; 2. Medical Plus, s.r.o; 3. Malopolskie Badania Kliniczne Sp. z o.o; 4. Reum-Medica S. C. Bozena Kowalewska, Marek Zawadzki; 5. University Hospital “Kaspela”, Medical University of Plovdiv; 6. Bio-Thera Solutions Ltd

PDF源文件 DOI 网页
118 天

Beyond the first switch: multiple switching, cross-switching, and nocebo-aware implementation of biosimilars in real-world care in non-US health systems

作者Ahmad Z. Al Meslamani; Anan S. Jarab; Husam El Sharu; Khadeijah Ahmed Al Marshoodi

作者单位1. Al Ain University; 2. Jordan University of Science and Technology; 3. Case Western Reserve University; 4. University of Sharjah

PDF源文件 DOI 网页
145 天

Exploring the potential benefits of allergen immunotherapy beyond respiratory allergy

作者Simone Foti Randazzese; Salvatore Barberi; Riccardo Castagnoli; Francesco Catamerò; Lorenzo Cosmi; Sara Guiducci; Lorenzo Lodi; Francesca Mori; Ivan Taietti; Sara Manti; Mattia Giovannini

作者单位1. University of Pavia; 2. Fondazione IRCCS Policlinico San Matteo; 3. ASST-Rhodense, RHO; 4. Meyer Children’s Hospital IRCCS; 5. University of Florence; 6. University of Messina

PDF源文件 DOI 网页
54 天

Combining biological matrices with growth factor concentrates: toward standardized protocols in regenerative medicine

作者Eduardo Anitua; María Troya; Roberto Tierno; Francisco Muruzabal; Mohammad H. Alkhraisat

作者单位1. BTI-Biotechnology Institute; 2. University Institute for Regenerative Medicine & Oral Implantology, UIRMI (UPV/EHU-Fundación Eduardo Anitua); 3. University of Jordan

PDF源文件 DOI 网页
87 天

Expanding indications of immune checkpoint inhibitors: a decade of success going strong

作者Victor M. Samperio; Ruba Alchaikh Hassan; Aishwarya Ghonge; Constantin A. Dasanu

作者单位1. Eisenhower Health; 2. Christus Health

PDF源文件 DOI 网页
44 天

Is incretin therapy the missing link to silencing residual inflammation in biologic-treated psoriasis?

作者Eva Klara Merzel Šabović; Miodrag Janić

作者单位1. University Medical Centre Ljubljana; 2. University of Ljubljana

PDF源文件 DOI 网页
91 天

Patient-centered approaches in psoriasis management: lessons from the past and future directions

作者Victoria McGuirt; Jake Breimann; Aarushi Gulati; William Huang; Steven Feldman

作者单位1. Wake Forest University School of Medicine; 2. Lewis Katz School of Medicine at Temple University; 3. A. T. Still University School of Osteopathic Medicine in Arizona; 4. University of North Carolina at Chapel Hill

PDF源文件 DOI 网页
105 天

Gene therapy approaches for inborn errors of immunity: from bench to bedside

作者Jasmeen Dara; Claire Booth

作者单位1. UCL Great Ormond Street Institute of Child Health; 2. Great Ormond Street Hospital

PDF源文件 DOI 网页
45 天

Originator versus biosimilar adalimumab in hidradenitis suppurativa: a real-world cohort study

作者Abdullah Demirbaş; Mustafa Esen; Esin Diremsizoğlu; Gözde Ulutaş Demirbaş

作者单位1. Kocaeli University Faculty of Medicine; 2. Dicle University Faculty of Medicine; 3. Kocaeli City Hospital

PDF源文件 DOI 网页
63 天

Twelve-month changes in lipid-derived cardiovascular risk indices among patients with psoriasis receiving biologic therapy: a multicenter real-world retrospective cohort study

作者Bahadır Aslancan; Nur Ecer; Ayşegül Tel Kankılıç; Ömer Karakoyun; Kadir Kaya

作者单位1. Şanlıurfa Training and Research Hospital; 2. Gazi Yaşargil Training and Research Hospital; 3. Ergani State Hospital; 4. Istinye University Hospital Medical Park Gaziosmanpaşa

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。